Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-RoussyJ Rouëssé, S Friedman, D Sarrazin, et al.
The New England Journal of Medicine|December 16, 1993
Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancerR Arriagada, T Le Chevalier, J P Pignon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 1, 1997
[Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma]J J Bretel, R Arriagada, T Le Chevalier, et al.
The Oncologist|February 22, 2001
Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancerT Le Chevalier, D Brisgand, J C Soria, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1984
Invasive carcinoma of the thymus. A multicenter retrospective review of 56 casesR Arriagada, J J Bretel, J M Caillaud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2aP Soulié, P Ruffié, L Trandafir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Surgery for lung metastases from colorectal cancer: analysis of prognostic factorsP Girard, M Ducreux, P Baldeyrou, et al.
British Journal of Cancer|January 1, 1997
Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancerP J Woll, R Basser, T Le Chevalier, et al.
Cancer|June 20, 2001
Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered?F Andre, D Grunenwald, J L Pujol, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancerT Le Chevalier, A Monnier, J Y Douillard, et al.
Pageof 18